GARAYEV, A. Et Al. 2017. Evaluation of “Programmed death-1”/”Programmed death ligand 1and 2” pathway in tumor samples of seminoma and non-seminoma, and its prognostic role in testicular cancers.. AMERICAN UROLOGİCAL ASSSOCIATION ANNUAL MEETING 2017 , 1082.

GARAYEV, A., BOZKURTLAR, E., FİLİNTE, D., ÇAM, H. K., ŞİMŞEK, F., & TİNAY, İ., (2017). Evaluation of “Programmed death-1”/”Programmed death ligand 1and 2” pathway in tumor samples of seminoma and non-seminoma, and its prognostic role in testicular cancers. . AMERICAN UROLOGİCAL ASSSOCIATION ANNUAL MEETING 2017 (pp.1082).

GARAYEV, ASGAR Et Al. "Evaluation of “Programmed death-1”/”Programmed death ligand 1and 2” pathway in tumor samples of seminoma and non-seminoma, and its prognostic role in testicular cancers.," AMERICAN UROLOGİCAL ASSSOCIATION ANNUAL MEETING 2017, 2017

GARAYEV, ASGAR Et Al. "Evaluation of “Programmed death-1”/”Programmed death ligand 1and 2” pathway in tumor samples of seminoma and non-seminoma, and its prognostic role in testicular cancers.." AMERICAN UROLOGİCAL ASSSOCIATION ANNUAL MEETING 2017 , pp.1082, 2017

GARAYEV, A. Et Al. (2017) . "Evaluation of “Programmed death-1”/”Programmed death ligand 1and 2” pathway in tumor samples of seminoma and non-seminoma, and its prognostic role in testicular cancers.." AMERICAN UROLOGİCAL ASSSOCIATION ANNUAL MEETING 2017 , p.1082.

@conferencepaper{conferencepaper, author={ASGAR GARAYEV Et Al. }, title={Evaluation of “Programmed death-1”/”Programmed death ligand 1and 2” pathway in tumor samples of seminoma and non-seminoma, and its prognostic role in testicular cancers.}, congress name={AMERICAN UROLOGİCAL ASSSOCIATION ANNUAL MEETING 2017}, city={}, country={}, year={2017}, pages={1082} }